4.5 Article

Clinical Characteristics and Therapeutic Outcomes of Metastatic Peritoneal Carcinomatosis in Non-Small-Cell Lung Cancer

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma

Agnieszka Rybarczyk-Kasiuchnicz et al.

Summary: Lung cancer is a common malignant neoplasm that may progress to metastasize to the central nervous system, affecting the prognosis unfavorably. The discovery of EGFR-activating mutations and ALK rearrangements in lung adenocarcinoma patients has led to the introduction of small-molecule tyrosine kinase inhibitors for advanced-stage treatment. These inhibitors target different pathways to improve progression-free survival in patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Cancer statistics, 2019

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Article Public, Environmental & Occupational Health

Peritoneal carcinomatosis, an unusual and only site of metastasis from lung adenocarcinoma

Kloub Hanane et al.

PAN AFRICAN MEDICAL JOURNAL (2016)

Article Oncology

Metastatic sites and survival in lung cancer

M. Riihimaeki et al.

LUNG CANCER (2014)

Article Respiratory System

Peritoneal carcinomatosis in lung cancer

Hsuan-Tsung Su et al.

RESPIROLOGY (2008)

Article Gastroenterology & Hepatology

Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients

Michiya Kobayashi et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2006)